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Abstract 
Background: Red yeast, Xanthophyllomyces dendrorhous is the only yeast known to produce astaxanthin, an anti-
oxidant isoprenoid (carotenoid) widely used in the aquaculture, food, pharmaceutical and cosmetic industries. The 
potential of this microorganism as a platform cell factory for isoprenoid production has been recognized because 
of high flux through its native terpene pathway. Recently, we developed a multiple gene expression system in X. 
dendrorhous and enhanced the mevalonate synthetic pathway to increase astaxanthin production. In contrast, the 
mevalonate synthetic pathway is suppressed by ergosterol through feedback inhibition. Therefore, releasing the 
mevalonate synthetic pathway from this inhibition through the deletion of genes involved in ergosterol synthesis is 
a promising strategy to improve isoprenoid production. An efficient method for deleting diploid genes in X. den-
drorhous, however, has not yet been developed.
Results: Xanthophyllomyces dendrorhous was cultivated under gradually increasing concentrations of antibiotics 
following the introduction of antibiotic resistant genes to be replaced with target genes. Using this method, double 
CYP61 genes encoding C-22 sterol desaturases relating to ergosterol biosynthesis were deleted sequentially. This 
double CYP61 deleted strain showed decreased ergosterol biosynthesis compared with the parental strain and single 
CYP61 disrupted strain. Additionally, this double deletion of CYP61 genes showed increased astaxanthin produc-
tion compared with the parental strain and the single CYP61 knockout strain. Finally, astaxanthin production was 
enhanced by 1.4-fold compared with the parental strain, although astaxanthin production was not affected in the 
single CYP61 knockout strain.
Conclusions: In this study, we developed a system to completely delete target diploid genes in X. dendrorhous. Using 
this method, we deleted diploid CYP61 genes involved in the synthesis of ergosterol that inhibits the pathway for 
mevalonate, which is a common substrate for isoprenoid biosynthesis. The resulting decrease in ergosterol biosynthe-
sis increased astaxanthin production. The efficient method for deleting diploid genes developed in this study has the 
potential to improve industrial production of various isoprenoids in X. dendrorhous.
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Background
Carotenoids are widely distributed in nature and are 
exclusively synthesized by plants and microorganisms 
[1]. Carotenoids belong to the natural compounds class 
of terpenes (isoprenoids) [2]. Bioproduction of pharma-
ceutically important carotenoids such as artemisinin 
and Taxol  precursor, has been accomplished by geneti-
cally engineered, well-characterized microorganisms 
such as Saccharomyces cerevisiae and Escherichia coli 
[3, 4]. Recently, however, Melillo, et  al. [5] showed the 
potential of red yeast, Phaffia rhodozyma (sexual form, 
Xanthophyllomyces dendrorhous), as a platform microor-
ganism for isoprenoid production because of the higher 
rates of flux through its native terpene pathway com-
pared with S. cerevisiae and E. coli. X. dendrorhous has 
been studied as a promising candidate microorganism for 
maximizing production of the carotenoid astaxanthin (3, 
3′-dihydroxy-β, β-carotene-4, 4′-dione; C40H52O4). Asta-
xanthin is used in fine chemical industries such as the 
food, pharmaceutical, and cosmetics industries because 
of its antioxidant properties [6, 7].
We previously identified strong promoters for the 
expression of target genes and developed a multi-gene 
expression system in X. dendrorhous [7, 8]. Astaxanthin 
production was enhanced by metabolic engineering using 
this system [8]. In contrast, high astaxanthin-producing 
mutant strains were previously obtained from randomly 
mutated strains [9, 10]. In most of these strains, the 
critical mutations for enhancing astaxanthin biosynthe-
sis have not been identified; however, these most likely 
involve a lack of genes affecting astaxanthin biosynthe-
sis. Thus, gene disruption was a very promising strategy 
to enhance astaxanthin production. However, a problem 
with random mutagenesis is the potential occurrence of 
unexpected mutations that could have negative effects on 
industrial astaxanthin production. Indeed, though asta-
xanthin content was increased by random mutagenesis, 
cell growth was inhibited [10]. A decrease in the final 
cell concentration has a negative effect on the volumetric 
concentration of astaxanthin, the most important factor 
for industrial astaxanthin production. Thus, a targeted 
gene disruption technique is required for deleting genes 
that negatively affect astaxanthin production. A gene 
deletion technique is essential for further improvement 
of astaxanthin production in X. dendrorhous. Two meth-
ods for the deletion of target genes in X. dendrorhous 
have been reported previously. Mauricio et  al. [11] 
reported the double recombinant method in 2008, where 
two different concentrations of antibiotics were used. 
Some researchers, including the authors, tried and failed 
to delete target genes using the double recombinant 
method [12, 13]. In contrast, Iris et  al. [14] reported a 
method to delete target diploid genes using two different 
antibiotic resistant genes. This method can be used for 
deletion of only two diploid genes because only four anti-
biotic-resistant genes have been known to work as antibi-
otic selection markers in X. dendrorhous.
In this study, we developed an easy and novel method 
for the double deletion of diploid target genes in X. den-
drorhous using one antibiotic resistant gene that saves 
selection markers. The outline of this new method is 
shown in Fig.  1. Using this method, we deleted both 
diploid CYP61 genes encoding C-22 sterol desaturases, 
which negatively regulate hydroxymethylglutaryl-coen-
zyme A (HMG-CoA) synthase (HmgS) and HMG-CoA 
reductase (HmgR) in the ergosterol biosynthesis, the 
rate-limiting enzymes in the mevalonate synthetic path-
way [14] (Fig.  2). The double deletion of diploid CYP61 
genes decreased the ergosterol biosynthesis, leading to 
improved astaxanthin production.
Results and discussion
An efficient method for double deletion of target genes 
in X. dendrorhous
We developed an efficient method for double deletion of 
target diploid genes in X. dendrorhous through a single 
genetic transformation event followed by cultivation with 
gradually increasing concentrations of antibiotics. This 
study targeted the diploid CYP61 genes for deletion to 
develop the method. It was expected that double deletion 
of CYP61 genes would suppress synthesis of ergosterol 
and, therefore, increase astaxanthin content by releasing 






























Fig. 1 The outline of a novel method for double deletion of diploid 
target genes in X. dendrorhous using one drug-resistant gene
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Firstly, the plasmid pKF-G418-gCYP61 digested 
with NdeI was transformed into the parental  X. den-
drorhous  host strain to construct the CYP61 single dis-
ruption strain [ΔCYP61(+, −)]. The genotype of the 
ΔCYP61(+, −) strain was confirmed by PCR using spe-
cific primers for the CYP61 gene and G418 resistant cas-
sette (Fig.  3a, b). Specific fragments of CYP61 (A and 
B) were confirmed in both the parental host strain and 
ΔCYP61(+, −) strain. Conversely, the specific fragments 
for the G418 resistant cassette (C and D) were confirmed 
in the ΔCYP61(+, −) strain, but not in the parental host 
strain. Furthermore, the theoretical length of fragment E 
from the G418 resistant cassette (4.5 kbp) appeared in the 
ΔCYP61(+, −) strain, while the CYP61 gene fragment 
(7.5  kbp) appeared in both the parental host strain and 
the ΔCYP61(+, −) strain. These results indicated that a 
single CYP61 gene was disrupted in the ΔCYP61(+, −) 
strain. This first disruption of a single target gene would 
be replaced using a genome editing technology such as 
the CRISPR-Cas9 system.
Next, we carried out disruption of both CYP61 genes 
because ergosterol biosynthesis of ΔCYP61(+, −) strain 
was almost equal to that of the parental strain as shown 
in Fig. 4 and described in detail in the following section 
“Ergosterol biosynthesis”. The sequential operations were 
carried out to cultivate ΔCYP61(+, −) strain up to a total 
concentration of 900  µg/mL G418, with the G418 con-
centration increasing in 100  µg/mL intervals. Dilutions 
of the culture with 900 µg/mL G418 were plated on solid 
YM medium containing 900 µg/mL G418 to obtain single 
Fig. 2 Astaxanthin biosynthesis and negative feedback regulation by ergosterol in X. dendrorhous. Astaxanthin is biosynthesized from acetyl-CoA 
through the pathway consists of the mevalonate, terpene, β-carotene and astaxanthin biosynthetic pathways. Astaxanthin biosynthesis was inhib-
ited through negative feedback regulation by ergosterol synthesized by CYP61 gene product. IPP isopentenyl-pyrophosphate, DMAPP dimethylallyl-
pyrophosphate, GPP geranyl-pyrophosphate, FPP farnesyl-pyrophosphate, GGPP geranylgeranyl-pyrophosphate, HMGS HMG-CoA synthase, HmgR 
HMG-CoA reductase, CrtE geranylgeranyl-pyrophosphate synthase, CrtS astaxanthin synthase. IPP and DMAPP are the isoprenoid building blocks 
and prenyltransferases generate GPP, FPP and GGPP, the common precursors of monoterpenoids (C10), sesquiterpenoids (C15) and diterpenoids 
(C20), respectively. Carotenoids (C40) such as astaxanthin are constructed by condensation of two molecules of GGPP
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colonies, some of which were then selected. The geno-
type of the ΔCYP61(−, −) strain was confirmed by PCR 
using specific primers for the CYP61 gene and the G418 
resistant cassette (Fig. 3). Like the ΔCYP61(+, −) strain, 
the specific fragments of the G418 resistant cassette (C 
and D) and the theoretical length of fragment E from the 
G418 resistant cassette (4500 bp) were confirmed in the 
ΔCYP61(−, −) strain. In contrast, the specific fragments 
for CYP61 (A and B) completely disappeared in the 
ΔCYP61(−, −) strain. These results indicated that both 
diploid CYP61 genes were successfully deleted in the 
ΔCYP61(−, −) strain. Five ΔCYP61(−, −) strains were 
obtained from 60 colonies. Homologous recombination 
between the disrupted and non-disrupted allele regions 
was used to delete the CYP61 gene from the ΔCYP61(+, 
−) strain. This was achieved by selection pressure applied 
through a gradual increase in antibiotic concentration.
Ergosterol biosynthesis
Ergosterol biosynthesis in the parental host strain, 
ΔCYP61(+, −) and ΔCYP61(−, −) was evaluated by 
reversed phase high-performance liquid chromatography 
(RP-HPLC). Chromatograms of ergosterol extractions 
from the parental host strain, ΔCYP61(+, −) strain and 
ΔCYP61(−, −) strain are shown in Fig. 4a. In the paren-
tal host strain and ΔCYP61(+, −) strain, a peak at 280 nm 
at 15.6 min was observed and identified as the ergosterol 
peak, confirmed by the addition of standard ergosterol. 
Conversely, this ergosterol peak was not observed in the 
ΔCYP61(−, −) strain. As shown in the time course of 
ergosterol concentrations (Fig.  4b), ergosterol biosynthe-
sis in the parental host strain and ΔCYP61(+, −) strain 
almost stopped after 24 h of cultivation. In contrast, ergos-
terol biosynthesis was not observed in the ΔCYP61(−, −) 
strain for more than 72 h from the start of the cultivation.
Astaxanthin fermentation
Astaxanthin production in the parental host strain, 
ΔCYP61(+, −) and ΔCYP61(−, −) was evaluated by RP-
HPLC. Cell growth, intracellular astaxanthin content, and 
volumetric astaxanthin concentrations extracted from 
these strains are shown in Fig. 5. After 24 h of fermenta-
tion, cell growth rate had been obviously slower than that 
before 24 h of fermentation, even in the parental host strain 
(Fig.  5a), which would explain why additional ergosterol 
biosynthesis was not observed after 24 h (Fig. 4b). The cell 
concentration of the ΔCYP61(−, −) strain was lower than 
that of the parental host strain until after 48 h of fermenta-
tion while that of the ΔCYP61(+, −) strain was almost the 
same as the parental strain (Fig. 5a). Because ergosterol is 
a component of the cell membrane, this slower cell growth 
is caused by the suppression of ergosterol biosynthesis. In 
contrast, after 48 h of fermentation, the cell growth of all 
strains had stopped because glucose would be depleted.
Conversely, astaxanthin production decreased after 
24 h of fermentation and was almost stopped after 48 h 
in the parental host strain and ΔCYP61(+, −) strain. 
In the ΔCYP61(−, −) strain, astaxanthin production 
instead continuously increased after 24 h of fermentation 
and gradually increased even after 48 h of fermentation 
(Fig.  5b). Finally, the volumetric astaxanthin concen-
tration after 72 h of fermentation of the ΔCYP61(−, −) 
strain (1.65 mg/L) was approximately 1.4-fold higher than 
that of the parental host strain (1.22 mg/L), although that 
of ΔCYP61(−, −) strain (1.25  mg/L) was not changed 
(Fig. 5c). These results indicate that astaxanthin produc-
tion was suppressed through feedback inhibition of the 













Wild type ∆CYP61(+,-) ∆CYP61(-,-)
A B C D E A B C D E A B C D E MMMM
b
Fig. 3 PCR-based analysis of CYP61 mutants. a The diagram shows 
the amplification target and each set of primers. b The gel shows PCR 
reactions performed with different sets of primers and genomic DNA 
from the parental strain (WT), ΔCYP61(+, −) strain and ΔCYP61(−, −) 
strain. Lanes A, B, C, D and E represent the fragment between primers 
#1 and #3 (1.5 kbp), #2 and #4 (2.0 kbp), #1 and #5 (1.8 kbp), #2 and 
#6 (1.6 kbp), and #1 and #2 (7.5 kbp for CYP61 gene and 4.5 kbp for 
G418R gene), respectively. The estimated sizes of the PCR fragments 
were represented in parenthesis. Lane M represent DNA marker and 
numbers on the right side show molecular weights of DNA marker
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diploid CYP61 genes was critical to release this feedback 
inhibition, with the single disruption of CYP61 having 
almost no effect on inhibition. The physiological concen-
tration of ergosterol needed for feedback inhibition of 
the mevalonate pathway can be estimated to be 10-fold 
higher than the concentration of astaxanthin according 
to the results of Figs. 4b and 5c. The fold-change increase 
in astaxanthin production following CYP61 gene deletion 
(1.6-fold) was almost equal to that (1.5-fold) caused by 
overexpression of genes involved in astaxanthin biosyn-
thetic metabolism [8]. In contrast to these overexpression 
strategies that used wild-type strains as the host strain, 
a greater fold-change increase in astaxanthin produc-
tion (3.4-fold) was observed when an astaxanthin-hyper 
Fig. 4 Ergosterol biosynthesis. a RP-HPLC ergosterol analysis from the parental host strain, ΔCYP61(+, −) and ΔCYP61(−, −). Chromatograms (at 
280 nm) correspond to ergosterol extracted from strains as described in the “Methods” section. Ergosterol extracts (black) from the parental host 
strain, ΔCYP61(+, −) strain and ΔCYP61(−, −) strain were analyzed with co-injection of ergosterol standard (pink). b Ergosterol production in the 
parental host strain, ΔCYP61(+, −) strain and ΔCYP61(−, −) strain. Circle (black), triangle (blue) and square (red) symbols represent values of the 
parental host strain, ΔCYP61(+, −) strain and ΔCYP61(−, −) strain, respectively. The values are means and the error bars show the standard deviation 
(n = 3)
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producing mutant strain generated by random mutagen-
esis was used as a host strain [15]. However, the problem 
of random mutagenesis is reduced in the cell growth of 
the host strain compared with the wild-type strain [15] 
because unexpected mutations occurring through ran-
dom mutagenesis, in addition to the expected mutations, 
result in enhanced astaxanthin biosynthesis [9, 10]. In 
contrast to random mutagenesis, the disruption of tar-
get genes carried out using the gene disruption method 
developed in this study did not decrease the final cell 
concentration because of the absence of any unexpected 
mutations. The developed strain has the potential to be 
one of the best strains for further improvement of asta-
xanthin production through metabolic engineering 
because it has an original metabolic background.
Conclusion
The two previously described methods for deletion of tar-
get diploid genes in X. dendrorhous had significant room 
for improvement. In this study, we developed an easy, 
novel method for double deletion of target genes from 
the diploid genome of X. dendrorhous through a single 
genetic transformation event followed by cultivation with 
gradually increasing antibiotic concentrations. Compared 
with previous methods, this method allows for efficient 
deletion of target genes while saving antibiotic resistant 
markers for use in deleting or overexpressing additional 
target genes. This method makes it possible to obtain 
strains that have completely lost the target allele. Indeed, 
we deleted double diploid CYP61 genes using this method 
and achieved improvement of astaxanthin production in 
X. dendrorhous. This method has the potential to improve 
industrial production of various isoprenoids in X. den-
drorhous without a decrease in cell growth.
Methods
Strains and media
NovaBlue (Novagen, Madison, WI, USA) was used as the 
E. coli host strain for recombinant DNA manipulation. 
X. dendrorhous (NBRC 10129) was used as the paren-
tal host strain for gene expression. E. coli transformants 
were grown in Luria broth medium (10  g/L tryptone, 
5  g/L yeast extract, and 5  g/L sodium chloride) supple-
mented with 100 µg/mL ampicillin. Transformants of X. 
dendrorhous were cultured in YM medium (5  g/L tryp-
tone, 3  g/L yeast extract, 3  g/L malt extract and 10  g/L 
glucose). Yeast extract and malt extract were purchased 
from Becton–Dickinson (Sparks, MD, USA). Other 
chemicals were obtained from Nacalai Tesque (Kyoto, 
Japan) or Wako Chemicals (Osaka, Japan).
Plasmid construction
Target genes were cloned by PCR using KOD-Plus-Neo 
DNA polymerase (Toyobo, Osaka, Japan). Nucleotide 
sequences of the cloning primers for target genes are 
shown in Additional file 1. To construct the G418 resist-
ant CYP61 disruption plasmid pKF-G418-gCYP61, the 
G418 resistance cassette was amplified by PCR from pKF-
G418-AAT [8] using the Pgpd-fw/Tgpd-rv forward and 
reverse primer set. The 5′- and 3′-homologous regions of 
CYP61 were also amplified by PCR from X. dendrorhous 
genomic DNA. The forward primer and reverse primer 
sets used for these amplifications were g-CYP61-5′-
fw/g-CYP61-5′-rv and g-CYP61-3′-fw/g-CYP61-3′-rv, 
Fig. 5 RP-HPLC ergosterol analysis from the parental host strain, 
ΔCYP61(+, −) strain and ΔCYP61(−, −) strain respectively, and 
astaxanthin production in each. a Cell concentration (OD600); b 
intracellular astaxanthin content (mg/g-cell). c volumetric astaxanthin 
concentration (mg/L). Circle (black), triangle (blue) and square (red) 
symbols represent values of the parental host strain, ΔCYP61(+, −) 
strain and ΔCYP61(−, −) strain, respectively
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respectively. These fragments were connected by PCR 
using g-CYP61-5′-fw/g-CYP61-3′-rv, generating the 
CYP61 disruption cassette. The length of the homologous 
sequence in the CYP61 disruption cassette was designed 
to be 1000 base pairs. This cassette was cloned into the 
NdeI digested pKF-G418-AAT fragment, which included 
AmpR, using the In-Fusion® HD Cloning Kit (Takara, 
Shiga, Japan), to construct pKF-G418-gCYP61.
Yeast transformation
Transformation was carried out using the method 
described in previous reports [11, 16] with some modifi-
cations for the construction of competent cells as follows. 
X. dendrorhous parental strains were grown in 5 mL liq-
uid YM medium at 22  °C with agitation at 250  rpm for 
24 h. Sufficient volumes of each culture were inoculated 
into 150  mL liquid YM medium to achieve initial val-
ues of 0.03 optical density at 600  nm (OD600). Cultures 
were then grown at 22  °C with agitation at 120 rpm for 
16.5  h. The NdeI digested plasmids pKF-G418-gCYP61 
were transformed into the parental X. dendrorhous host 
strain to construct the CYP61 single disruption strain 
(ΔCYP61(+, −)).
Double deletion of CYP61 genes from genome in X. 
dendrorhous
The ΔCYP61(+, −) strain was cultivated in a test tube 
containing 5 mL of yeast mold (YM) media with 40 µg/
mL of G418, incubated at 22 °C with agitation at 250 rpm 
for 24 h. A 200 µL aliquot of the culture was then inoc-
ulated into 5 mL YM medium plus 100 µg/mL of G418. 
After sufficient growth at 22 °C with agitation at 250 rpm, 
a 200 µL aliquot of the culture was inoculated into 5 mL 
YM medium plus 200 µg/mL G418. The sequential oper-
ations were carried out up to a total concentration of 
900  µg/mL G418, with the G418 concentration increas-
ing in 100  µg/mL intervals. Dilutions of the culture 
with 900 µg/mL G418 were plated on solid YM medium 
containing 900  µg/mL G418 to obtain single colonies, 
some of which were then selected. The genotype of the 
ΔCYP61(−, −) strain was confirmed by PCR using spe-
cific primers for the CYP61 gene and the G418 resistant 
cassette.
Astaxanthin fermentation of X. dendrorhous strains
Xanthophyllomyces dendrorhous strains with deleted tar-
get genes were grown in 5 mL liquid YM medium, also 
containing 40  µg/mL G418 as required, in test tubes at 
22  °C with agitation at 250 rpm for 24 h. Sufficient vol-
umes of each culture were inoculated into 80 mL liquid 
YM medium in a Sakaguchi flask to achieve initial OD600 
values of 0.15. Cells were then grown at 22 °C with agita-
tion at 120 rpm for less than 72 h.
Extraction and RP‑HPLC measurement of astaxanthin 
and ergosterol
Cell concentration was measured as OD600 after cul-
turing for the appropriate time. The cell mass (dry cell 
weight) was calculated by 0.3786 × OD600. To measure 
the intracellular astaxanthin content of X. dendrorhous 
mutants, harvested cells were suspended in 1  mL ace-
tone. The cells were broken using a bead shaker (Shake 
Master NEO, BMS, Tokyo, Japan) with zirconia beads. 
The cell extract was centrifuged at 8000×g at 4  °C for 
10  min and the supernatant was then diluted with an 
appropriate volume of acetone for cover the range of fol-
lowing HPLC assay.
Astaxanthin concentration was determined using 
a HPLC machine (Shimadzu, Kyoto, Japan) equipped 
with a Develosil ODS-HG-5 column (Nomura Chemi-
cal, Aichi, Japan). The operating conditions were a tem-
perature of 25 °C, with acetonitrile/methanol/2-propanol 
(85/10/5 [v/v]) as the mobile phase at a flow rate of 
0.8 mL/min, and the detection was performed at 471 nm 
with a UV detector SPD-20A (Shimadzu).
Ergosterol concentration was also determined using a 
HPLC machine (Shimadzu) equipped with a Develosil 
ODS-HG-5 column (Nomura Chemical). The operating 
conditions were a temperate of 30  °C, with methanol/
water (97/3 [v/v]) as the mobile phase at a flow rate of 
1.0 mL/min, and the detection was performed at 280 nm 
with a UV detector SPD-20A (Shimadzu).
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